Literature DB >> 21857377

Changes in epigenetic regulation of CD4+ T lymphocytesin biliary atresia.

Rui Dong1, Rui Zhao, Shan Zheng.   

Abstract

Biliary atresia (BA) is a virus-induced autoimmune disease associated with abnormal DNA methylation patterns that contribute to disease presentation. This study examined DNA methylation patterns, changes to genes associated with methylation regulation, and changes to the autoimmune-related gene interferon gamma (IFN-γ) in CD4+ T cells from BA patients. We demonstrated that genomic DNA isolated from CD4+ T cells harvested from infants presenting with BA were hypomethylated relative to healthy controls. In addition, DNA methyltransferase (DNMT1) and DNMT3a mRNA levels were significantly lower in BA CD4+ T cells compared with controls and methyl-DNA-binding domain proteins (MBD1) mRNA expression (but not MBD4 detected at higher levels in BA patients), which was significantly lower in CD4+ T cells from BA infants than in controls. DNMT1 expression positively correlated with global DNA methylation in BA CD4+ T cells. IFN-γ mRNA expression levels in BA patients were also significantly increased, and the IFN-γ gene promoter region was hypomethylated in BA CD4+ T cells compared with controls and negatively correlated with DNA methylation. These data suggest that methylation changes in CD4+ cells may contribute to BA disease presentation and progression by affecting the expression of genes associated with autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21857377     DOI: 10.1203/PDR.0b013e318232a949

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  13 in total

Review 1.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

Review 2.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

Review 3.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

Review 4.  Clinical implications of interferon-γ genetic and epigenetic variants.

Authors:  Nicola L D Smith; David W Denning
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

Review 5.  Aetiology of biliary atresia: what is actually known?

Authors:  Claus Petersen; Mark Davenport
Journal:  Orphanet J Rare Dis       Date:  2013-08-29       Impact factor: 4.123

6.  Methylation Microarray Studies Highlight PDGFA Expression as a Factor in Biliary Atresia.

Authors:  Zenobia C Cofer; Shuang Cui; Steven F EauClaire; Cecilia Kim; John W Tobias; Hakon Hakonarson; Kathleen M Loomes; Randolph P Matthews
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

7.  Global methylation, oxidative stress, and relative telomere length in biliary atresia patients.

Authors:  Wanvisa Udomsinprasert; Nakarin Kitkumthorn; Apiwat Mutirangura; Voranush Chongsrisawat; Yong Poovorawan; Sittisak Honsawek
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

Review 8.  Biliary atresia: Where do we stand now?

Authors:  Krishna Kumar Govindarajan
Journal:  World J Hepatol       Date:  2016-12-28

9.  Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia.

Authors:  Wanvisa Udomsinprasert; Nakarin Kitkumthorn; Apiwat Mutirangura; Voranush Chongsrisawat; Yong Poovorawan; Sittisak Honsawek
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

10.  MicroRNA-29b/142-5p contribute to the pathogenesis of biliary atresia by regulating the IFN-γ gene.

Authors:  Yifan Yang; Zhu Jin; Rui Dong; Chao Zheng; Yanlei Huang; Yijie Zheng; Zhen Shen; Gong Chen; Xiaoying Luo; Shan Zheng
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.